We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£595.00
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants Excluding Non-Drug Dietaries for Weight Control in the United States
Price data last checked 70 day(s) ago - refreshing...
Price History & Forecast
Last 21 days • 21 data points (No recent data available)
Price Distribution
Price distribution over 21 days • 1 price levels
Price Analysis
Most common price: £595 (21 days, 100.0%)
Price range: £595 - £595
Price levels: 1 different prices over 21 days
Product Specifications
- Format
- paperback
- ASIN
- B01DWQ6G2Y
- Domain
- Amazon UK
- Release Date
- 29 September 2015
- Listed Since
- 06 April 2016
Similar Products You Might Like
98% match
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants Excluding Non-Drug Dietaries for Weight Control in Greater China
£595.00
12 Jan 2026
97% match
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants Excluding Non-Drug Dietaries for Weight Control in Japan
£595.00
10 Feb 2026
97% match
The 2016-2021 Outlook for Diet Aids Containing Local Anesthetics Excluding Non-Drug Dietaries for Weight Control and Bulk-Only Diet Aids in the United States
£595.00
12 Jan 2026
96% match
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants and Anorexiants Excluding Amphetamines in Greater China
£595.00
30 Jan 2026
96% match
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants and Anorexiants Excluding Amphetamines in Japan
£595.00
16 Feb 2026
96% match
The 2016-2021 Outlook for Neurostimulation Devices in the United States
£595.00
25 Jan 2026
96% match
The 2016-2021 World Outlook for Diet Aids Containing Local Anesthetics Excluding Non-Drug Dietaries for Weight Control and Bulk-Only Diet Aids
£995.00
13 Jan 2026
96% match
The 2016-2021 Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs in the United States
£595.00
28 Jan 2026
96% match
The 2016-2021 Outlook for Prescription Narcotic Cough Preparations and Expectorants in the United States
£595.00
25 Jan 2026
96% match
The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in the United States
£595.00
10 Mar 2026
96% match
The 2016-2021 Outlook for Pharmaceutical Preparations for Human Use Acting on the Central Nervous System and the Sense Organs in the United States
£595.00
27 Jan 2026
95% match
The 2016-2021 Outlook for Tobacco and Non-Tobacco Cigarettes in the United States
£595.00
12 Jan 2026
95% match
The 2016-2021 Outlook for Non-Prescription Decongestants Excluding Nasal Sprays and Nose Drops in the United States
£595.00
28 Jan 2026
95% match
The 2016-2021 Outlook for Pulmonary Drug Delivery Systems in the United States
£595.00
30 Jan 2026
95% match
The 2016-2021 Outlook for Phytosterols in the United States
£595.00
22 Jan 2026
95% match
The 2016-2021 Outlook for Non-Prescription Cough Syrups in the United States
£595.00
14 Jan 2026
95% match
The 2016-2021 Outlook for Erythropoietins in the United States
£595.00
01 Feb 2026
95% match
The 2016-2021 Outlook for Non-Electronic Games in the United States
£595.00
25 Jan 2026
95% match
The 2016-2021 Outlook for Diet Aids Containing Local Anesthetics Excluding Non-Drug Dietaries for Weight Control and Bulk-Only Diet Aids in Japan
£595.00
14 Jan 2026
95% match
The 2016-2021 Outlook for Motion Sickness Medications in the United States
£595.00
25 Jan 2026
95% match
The 2016-2021 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in the United States
£595.00
24 Jan 2026
95% match
The 2016-2021 Outlook for Sports and Fitness Nutrition in the United States
£595.00
01 Feb 2026
95% match
The 2016-2021 Outlook for Respiratory Care Equipment and Supplies in the United States
£595.00
13 Jan 2026
95% match
The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States
£595.00
14 Jan 2026